| Description | Eldacimibe (WAY-ACA-147) is an ACAT2 inhibitor for the treatment of cardiovascular disease and endocrine and metabolic disorders, study of atherosclerosis and hypercholesterolemia. |
| Synonyms | WAY-ACA-147, UNII-4PBL76O2G8, ANA 147, ACA 147 |
| molecular weight | 634.89 |
| Molecular formula | C39H58N2O5 |
| CAS | 141993-70-6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 50 mg/mL (78.75 mM) |
| References | 1. Siegfried Hekimi, et al. Acat inhibitors and their use in the prevention or treatment of fibrosis. WO2008058383A1. 2. Chhabria MT, et al. Update on patented cholesterol absorption inhibitors. Expert Opin Ther Pat. 2009;19(8):1083-1107. |